Patient eligibility and trial design for the salvage therapy of advanced urothelial carcinoma Journal Article


Authors: Sonpavde, G.; Bellmunt, J.; Rosenberg, J. E.; Regazzi, A. M.; Bajorin, D. F.; Choueiri, T. K.; Qu, A. Q.; Niegisch, G.; Albers, P.; Necchi, A.; di Lorenzo, G.; Fougeray, R.; Wong, Y. N.; Sridhar, S. S.; Ko, Y. J.; Milowsky, M. I.; Galsky, M. D.; Pond, G. R.
Article Title: Patient eligibility and trial design for the salvage therapy of advanced urothelial carcinoma
Keywords: cancer chemotherapy; cancer survival; treatment response; overall survival; review; salvage therapy; advanced cancer; patient selection; systemic therapy; progression free survival; antineoplastic metal complex; age; comorbidity; age distribution; drug sensitivity; transitional cell carcinoma; randomized controlled trial (topic); study design; phase 2 clinical trial (topic); phase 3 clinical trial (topic); cancer prognosis; human; patient history of chemotherapy
Journal Title: Clinical Genitourinary Cancer
Volume: 12
Issue: 6
ISSN: 1558-7673
Publisher: Elsevier Inc.  
Date Published: 2014-12-01
Start Page: 395
End Page: 398
Language: English
DOI: 10.1016/j.clgc.2014.03.016
PROVIDER: scopus
PUBMED: 25035282
DOI/URL:
Notes: Export Date: 2 March 2015 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Dean Bajorin
    657 Bajorin
  2. Ashley Regazzi
    89 Regazzi
  3. Jonathan Eric Rosenberg
    510 Rosenberg